Last updated on June 2020

Phase II Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Non-small Cell Lung Cancer (NSCLC)


Find a site near you

Start Over

GSK Investigational Site

Kansas City, MO United States
  Connect »

GSK Investigational Site

Pinehurst, NC United States
  Connect »

GSK Investigational Site

Nashville, TN United States
  Connect »

GSK Investigational Site

Dallas, TX United States
  Connect »

GSK Investigational Site

Villejuif Cedex, France
  Connect »

GSK Investigational Site

Cheongju-si, Chungcheongbuk-do, Korea, Republic of
  Connect »

GSK Investigational Site

Gyeonggi-do, Korea, Republic of
  Connect »

GSK Investigational Site

Seongnam, Korea, Republic of
  Connect »

GSK Investigational Site

Seoul, Korea, Republic of
  Connect »

GSK Investigational Site

Maastricht, Netherlands
  Connect »

GSK Investigational Site

Chelyabinsk, Russian Federation
  Connect »

GSK Investigational Site

Saint-Petersburg, Russian Federation
  Connect »

GSK Investigational Site

Saint Louis, MO United States
  Connect »

GSK Investigational Site

Atlanta, GA United States
  Connect »

GSK Investigational Site

Southfield, MI United States
  Connect »

GSK Investigational Site

Hackensack, NJ United States
  Connect »

GSK Investigational Site

Bellevue, WA United States
  Connect »

GSK Investigational Site

Bronx, NY United States
  Connect »

GSK Investigational Site

Chattanooga, TN United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.